In her final president’s column, Karen Kafadar talks about her accomplishments from the past year, challenges ahead, and—last but most important—her experiences with members like you.

Lisa LaVange, director of the Office of Biostatistics in the Center for Drug Evaluation and Research at the U.S. Food and Drug Administration, has been elected the 113th president of the ASA. LaVange will serve a one-year term as president-elect beginning January 1, 2017. Her term as president becomes effective January 1, 2018. The ASA membership also elected G. David Williamson, senior science adviser at the U.S. Centers for Disease Control and Prevention, as an ASA vice president.
Members also elected several new board members, plus officers for each of the ASA’s 27 sections.